Electromed (ELMD) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.01% |
| Dec 31, 2025 | 22.38% |
| Sep 30, 2025 | 19.11% |
| Jun 30, 2025 | 23.59% |
| Mar 31, 2025 | 26.65% |
| Dec 31, 2024 | 32.45% |
| Sep 30, 2024 | 27.12% |
| Jun 30, 2024 | 17.83% |
| Mar 31, 2024 | 14.95% |
| Dec 31, 2023 | 11.52% |
| Sep 30, 2023 | 7.60% |
| Jun 30, 2023 | -4.82% |
| Mar 31, 2023 | -2.69% |
| Dec 31, 2022 | 2.44% |
| Sep 30, 2022 | -12.98% |
| Jun 30, 2022 | 20.93% |
| Mar 31, 2022 | 4.91% |
| Dec 31, 2021 | 17.17% |
| Sep 30, 2021 | 17.92% |
| Jun 30, 2021 | 31.06% |
| Mar 31, 2021 | 49.06% |
| Dec 31, 2020 | 27.83% |
| Sep 30, 2020 | 37.30% |
| Jun 30, 2020 | 48.00% |
| Mar 31, 2020 | 42.11% |
| Dec 31, 2019 | 58.50% |
| Sep 30, 2019 | 69.31% |
| Jun 30, 2019 | 87.46% |
| Mar 31, 2019 | 93.61% |
| Dec 31, 2018 | 56.48% |
| Sep 30, 2018 | 45.49% |
| Jun 30, 2018 | 42.75% |
| Mar 31, 2018 | 36.60% |
| Dec 31, 2017 | 34.16% |
| Sep 30, 2017 | 35.74% |
| Jun 30, 2017 | 22.31% |
| Mar 31, 2017 | 31.86% |
| Dec 31, 2016 | 32.21% |
| Sep 30, 2016 | 28.60% |
| Jun 30, 2016 | 20.95% |
| Mar 31, 2016 | 0.53% |
| Dec 31, 2015 | 10.06% |
| Sep 30, 2015 | -1.81% |